468 related articles for article (PubMed ID: 16112400)
1. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
[TBL] [Abstract][Full Text] [Related]
2. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on food intake and locomotor activity in the goldfish, Carassius auratus.
Matsuda K; Maruyama K; Nakamachi T; Miura T; Shioda S
Ann N Y Acad Sci; 2006 Jul; 1070():417-21. PubMed ID: 16888202
[TBL] [Abstract][Full Text] [Related]
3. Anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: feeding-induced changes in the expression of mRNAs for PACAP and its receptors in the brain, and locomotor response to central injection.
Matsuda K; Maruyama K; Miura T; Uchiyama M; Shioda S
Neurosci Lett; 2005 Sep; 386(1):9-13. PubMed ID: 15975713
[TBL] [Abstract][Full Text] [Related]
4. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
[TBL] [Abstract][Full Text] [Related]
5. Regulation of feeding behavior by pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) in vertebrates.
Matsuda K; Maruyama K
Peptides; 2007 Sep; 28(9):1761-6. PubMed ID: 17466413
[TBL] [Abstract][Full Text] [Related]
6. Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout.
Le Mével JC; Lancien F; Mimassi N; Conlon JM
J Exp Biol; 2009 Dec; 212(Pt 23):3919-27. PubMed ID: 19915135
[TBL] [Abstract][Full Text] [Related]
7. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks.
Tachibana T; Oikawa D; Adachi N; Boswell T; Furuse M
Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):156-64. PubMed ID: 17291802
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular injection of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibits feeding in chicks.
Tachibana T; Saito S; Tomonaga S; Takagi T; Saito ES; Boswell T; Furuse M
Neurosci Lett; 2003 Mar; 339(3):203-6. PubMed ID: 12633888
[TBL] [Abstract][Full Text] [Related]
9. Relationship between anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) and that of corticotropin-releasing hormone (CRH) in the goldfish, Carassius auratus.
Maruyama K; Miura T; Uchiyama M; Shioda S; Matsuda K
Peptides; 2006 Jul; 27(7):1820-6. PubMed ID: 16519959
[TBL] [Abstract][Full Text] [Related]
10. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
[TBL] [Abstract][Full Text] [Related]
12. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
13. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
[TBL] [Abstract][Full Text] [Related]
15. Intestinal adaptation in atrophic rat ileum is accompanied by supersensitivity to vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide and nitric oxide.
Ekelund M; Ekblad E
Scand J Gastroenterol; 2001 Mar; 36(3):251-7. PubMed ID: 11305511
[TBL] [Abstract][Full Text] [Related]
16. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide inhibit feeding in the chick brain by different mechanisms.
Tachibana T; Tomonaga S; Oikawa D; Saito S; Takagi T; Saito ES; Boswell T; Furuse M
Neurosci Lett; 2003 Sep; 348(1):25-8. PubMed ID: 12893417
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
Delgado M; Martinez C; Pozo D; Calvo JR; Leceta J; Ganea D; Gomariz RP
J Immunol; 1999 Jan; 162(2):1200-5. PubMed ID: 9916753
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP
J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
